Relapse Of Severe Asthma Exacerbations After Cessation Of Omalizumab Treatment - Real Life Data

被引：0
|
作者：
Kuprys-Lipinska, Izabela R. [1 ]
Kuna, Piotr [1 ]
机构：
[1] Med Univ Lodz, Dept Internal Med Asthma & Allergy, Lodz, Poland
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2014年 / 133卷 / 02期
关键词：
D O I：
10.1016/j.jaci.2013.12.026
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
2
引用
收藏
页码：AB1 / AB1
页数：1
相关论文
共 50 条
  • [41] Predictors of response to therapy with omalizumab in patients with severe allergic asthma - a real life study
    Kallieri, Maria
    Papaioannou, Andriana I.
    Papathanasiou, Evgenia
    Ntontsi, Polyxeni
    Papiris, Spyridon
    Loukides, Stelios
    POSTGRADUATE MEDICINE, 2017, 129 (06) : 598 - 604
  • [42] Omalizumab discontinuation in children with severe allergic asthma: An observational real-life study
    Deschildre, Antoine
    Roussel, Juliette
    Drumez, Elodie
    Abou-Taam, Rola
    Rames, Cinthia
    Le Roux, Pascal
    Pouessel, Guillaume
    Scalbert, Manuela
    Bonnel, Cecile
    Mitha, Sarah
    Boileau, Sophie
    Mordacq, Clemence
    Thumerelle, Caroline
    Labreuche, Julien
    Lejeune, Stephanie
    Marguet, Christophe
    ALLERGY, 2019, 74 (05) : 999 - 1003
  • [43] Omalizumab in patients with severe persistent allergic asthma in a real-life setting in Germany
    Korn, S.
    Thielen, A.
    Seyfried, S.
    Taube, C.
    Kornmann, O.
    Buhl, R.
    RESPIRATORY MEDICINE, 2009, 103 (11) : 1725 - 1731
  • [44] Real-life data of ten years with omalizumab treatment
    Karayazi, Damla Gunduz
    Simsek, Gokcen Omeroglu
    Sevinc, Can
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [45] Omalizumab In The Treatment Of Severe Persistent Bakers Asthma
    Ruiz Garcia, M.
    Fernandez Nieto, M.
    Manso Alonso, L.
    Sastre Dominguez, J.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2011, 127 (02) : AB179 - AB179
  • [46] Omalizumab for the treatment of severe persistent allergic asthma
    Jones, J.
    Shepherd, J.
    Hartwell, D.
    Harris, P.
    Cooper, K.
    Takeda, A.
    Davidson, P.
    HEALTH TECHNOLOGY ASSESSMENT, 2009, 13 : 31 - 39
  • [47] Omalizumab in the treatment of severe persistent bakers asthma
    Ruiz Garcia, M.
    Fernandez-Nieto, M.
    Manso Alonso, L.
    Sastre Dominguez, J.
    ALLERGY, 2010, 65 : 655 - 655
  • [48] The effect of treatment with omalizumab, an anti-IgE antibody, on asthma exacerbations and emergency medical visits in patients with severe persistent asthma
    Bousquet, J
    Cabrera, P
    Berkman, N
    Buhl, R
    Holgate, S
    Wenzel, S
    Fox, H
    Hedgecock, S
    Blogg, M
    Della Cioppa, G
    ALLERGY, 2005, 60 (03) : 302 - 308
  • [49] Improvement of patient-reported outcomes in severe allergic asthma by omalizumab treatment: the real life observational PROXIMA study
    Canonica, Giorgio Walter
    Rottoli, Paola
    Bucca, Caterina
    Zappa, Maria Cristina
    Michetti, Giovanni
    Macciocchi, Bruno
    Caruso, Cristiano
    Santus, Pierachille
    Bartezaghi, Marta
    Rigoni, Laura
    WORLD ALLERGY ORGANIZATION JOURNAL, 2018, 11
  • [50] Real-life study in non-atopic severe asthma patients achieving disease control by omalizumab treatment
    Campo, Paloma
    Soto Campos, Gregorio
    Moreira, Ana
    Quirce, Santiago
    Padilla-Galo, Alicia
    Martinez-Moragon, Eva
    Mardones, Aizea
    Davila, Ignacio
    ALLERGY, 2021, 76 (06) : 1868 - 1872
12345